RVMD
|
Revolution Medicines, Inc.
|
0.02%
|
US
|
NASDAQ
|
RLAY
|
Relay Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
0.02%
|
US
|
NASDAQ
|
RDNT
|
RadNet, Inc.
|
0.02%
|
US
|
NASDAQ
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
QURE
|
uniQure N.V.
|
0.02%
|
US
|
NASDAQ
|
NXGN
|
NextGen Healthcare, Inc.
|
0.02%
|
US
|
NASDAQ
|
NVAX
|
Novavax, Inc.
|
0.02%
|
US
|
NASDAQ
|
MYOV
|
Myovant Sciences Ltd.
|
0.02%
|
US
|
NYSE
|
MODV
|
ModivCare Inc.
|
0.02%
|
US
|
NASDAQ
|
MNKD
|
MannKind Corporation
|
0.02%
|
US
|
NASDAQ
|
LMAT
|
LeMaitre Vascular, Inc.
|
0.02%
|
US
|
NASDAQ
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
0.02%
|
US
|
NASDAQ
|
KYMR
|
Kymera Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
KRYS
|
Krystal Biotech, Inc.
|
0.02%
|
US
|
NASDAQ
|
IMGN
|
ImmunoGen, Inc.
|
0.02%
|
US
|
NASDAQ
|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
0.02%
|
US
|
NASDAQ
|
FGEN
|
FibroGen, Inc
|
0.02%
|
US
|
NASDAQ
|
ESTA
|
Establishment Labs Holdings Inc.
|
0.02%
|
US
|
NASDAQ
|
DVAX
|
Dynavax Technologies Corporation
|
0.02%
|
US
|
NASDAQ
|